0
Tech & Innovation·April 9, 2026·1 min read

AbbVie suggests new interpretation of 'patient' is necessary in 340B lawsuit

Share

AbbVie’s push to redefine “patient” in 340B is a margin defense play — whoever controls that definition controls billions in discount exposure and channel strategy. Manufacturers and providers should model revenue and access under narrower and broader “patient” scopes now, because once a new definition lands it will be too late to re-architect contracts and distribution.